Skip to main content
Equibles

DUPONT CAPITAL MANAGEMENT CORP

Position in SLXN — Silexion Therapeutics Corp

CIK 1128251 Wilmington, DE
Back to SLXN Full portfolio

Position in SLXN

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$0
+$0 QoQ
Shares Held
32,500
0.0% QoQ
Ownership
0.585%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLXN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DUPONT CAPITAL MANAGEMENT CORP holds $210 across 6 Biotechnology names. SLXN ranks #6 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AEON
AEON Biopharma, Inc.
 170 $122
2 OCS
Oculis Holding AG
 4 $55
3 NAMS
NewAmsterdam Pharma Co N.V.
 1 $33
4 TVGN
Tevogen Inc.
 12,500 $0
5 LIMN
Liminatus Pharma, Inc.
 6,250 $0
6 SLXN
Silexion Therapeutics Corp
This page 		32,500 $0

No Holdings History

No holdings records found for this institution in SLXN.